Annals of the Rheumatic Diseases 2005;64:722-729
© 2005 by BMJ Publishing Group Ltd & European League Against Rheumatism
EXTENDED REPORT
Analysis of the CD8+ T cell response to the G1 domain of aggrecan in ankylosing spondylitis
1 Department of Gastroenterology and Rheumatology, Charité Berlin, Campus Benjamin Franklin, Berlin, Germany
2 German Rheumatology Research Centre, Berlin, Germany
Correspondence to:
Dr J Sieper
Department of Gastroenterology and Rheumatology, Charité Berlin, Campus Benjamin Franklin, Hindenburgdamm 30, 12200 Berlin, Germany; joachim.sieper{at}charite.de
Background: CD4+ T cell responses to the G1 domain of aggrecan in patients with ankylosing spondylitis (AS) were recently reported. Whether such an immune response can be seen in the CD8+ subpopulation has not yet been determined.
Objective: To determine if HLA-B27 restricted G1-specific CD8+ T cells are present in AS and to analyse immunodominant CD8+ T cell epitopes.
Methods: Peripheral blood mononuclear cells of 45 patients with AS were stimulated with overlapping 18-mer peptides covering the whole G1 protein. Results were compared with those for patients with rheumatoid arthritis (RA) and healthy controls. For epitope analysis, G1-specific interferon gamma positive (IFN
+) T cells were isolated by magnetic activated cell sorting. After in vitro expansion, CD8+ T cells were restimulated with 14 subpools of G1 peptides. T cells responding to G1 peptide subpools were quantified by flow cytometry according to IFN
secretion. Predicted peptides were subsequently confirmed by stimulation with single peptides.
Results: G1-specific CD8+ T cell responses were found in 29/45 (64%) patients with AS, 18/35 (51%) patients with RA, but not in healthy controls. Five CD8+ T cell epitopes were identified as immunodominant in five patients. However, the T cell response was not HLA-B27 restricted. Nonamer peptides with an HLA-B27 binding motif did not induce a T cell response.
Conclusion: A G1 peptide-specific CD8+ T cell response is present in AS but also in patients with RA. It does not seem to be HLA-B27 restricted. Whether such a response has a role in the pathogenesis of AS needs clarification.
Abbreviations: AA, amino acid; AS, ankylosing spondylitis; IFN
, interferon
; IL, interleukin; MACS, magnetic activated cell sorting; PB, peripheral blood; PBMCs, peripheral blood mononuclear cells; RA, rheumatoid arthritis; SEB, Staphylococcus enterotoxin B; TNF
, tumour necrosis factor 
Keywords: CD8+ T cells; aggrecan; ankylosing spondylitis; self antigens
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
